Caption Management, LLC Legend Biotech Corp Call Options Transaction History

Caption Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$39.5 - $57.22 $12.4 Million - $18 Million	-314,200 Reduced 86.27%	50,000 $2.21 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $4.72 Million - $6 Million	85,700 Added 30.77%	364,200 $20.4 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $12.8 Million - $15.6 Million	224,000 Added 411.01%	278,500 $16.8 Million
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $11.6 Million - $14 Million	-183,000 Reduced 77.05%	54,500 $3.66 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $6.59 Million - $10.7 Million	142,500 Added 150.0%	237,500 $16.4 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $4.12 Million - $5.45 Million	95,000 New	95,000 $4.58 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $686,700 - $1.03 Million	18,000 Added 60.0%	48,000 $1.96 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $1.01 Million - $1.65 Million	30,000 New	30,000 $1.65 Million
Q4 2021 Feb 11, 2022	SELL	$41.14 - $56.98 $1.23 Million - $1.71 Million	-30,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$35.31 - $50.56 $529,650 - $758,400	-15,000 Reduced 33.33%	30,000 $1.52 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $1.16 Million - $1.85 Million	45,000 New	45,000 $1.85 Million

205

74.5M

371K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.